Saladax Biomedical’s FDA-Cleared Clozapine Assay
The FDA-cleared clozapine assay seeks to redefine the landscape of clozapine therapeutic drug monitoring and patient management.
The FDA-cleared clozapine assay seeks to redefine the landscape of clozapine therapeutic drug monitoring and patient management.
Researchers have built a new, easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly.
The Center of BioModular Multi-Scale Systems for Precision Medicine creates rapid tests for human ailments like cancer, stroke, and COVID.
A portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer.
Read MoreThe FDA alerted that false reactivity Rapid Plasma Reagin test results in a Bio-Rad RPR kit can occur for some who received a COVID-19 vaccine.
Read MoreLumiraDx’s SARS-CoV-2 assay will now offer a self-collected COVID-19 nasal specimen collection kit through a new partnership with Audere.
Read MoreA new study found COVID-19 rapid antigen detection tests proved more effective than expected when compared to the polymerase chain reaction (PCR) assay.
Read MoreThe LumiraDx SARS-CoV-2 RNA STAR Complete has been authorized by FDA for emergency use under an EUA for use by authorized laboratories.
Read MoreThe Maverick line of qPCR instruments from Anitoa Systems has received U.S. FDA registration and device listing as class II 510(k) exempt medical devices.
Read MoreWhile welcoming a renewed emphasis on testing, some healthcare leaders warn that America’s path forward requires balancing testing speed with accuracy.
Read MoreRockefeller University’s “DRUL” saliva test performs as well as, if not better, than FDA-authorized nasal and oral swab tests.
Read MoreVisby Medical has received a 510(k) clearance to market its fast, single-use PCR diagnostic test for the detection of STIs.
Read MoreBD has announced the U.S. FDA has issued an Emergency Use Authorization (EUA) for the BD Veritor At-Home COVID-19 Test.
Read MoreNew England Biolabs (NEB) has released its newest loop-mediated isothermal amplification (LAMP) products, allowing for rapid, high throughput tests.
Read MoreQIAGEN has received emergency use authorization (EUA) from the FDA for its QIAreach SARS CoV-2 Antigen Test.
Read MoreAcupath is part of a select group of laboratory providers in the greater NYC area meeting the COVID-19 testing needs for international travel.
Read MoreCityHealth, a provider of urgent care and COVID testing solutions, has launched a COVID testing solution for travelers.
Read MoreiXensor Co., Ltd. has launched a new version of its integrated COVID-19 screening solution, the PixoHealth Pass Admin App and Web Portal.
Read More